Only a clinical trial supply chain partner that exhibits global regulatory and trade compliance proficiency and transports shipments in a secure, compliant, closed-loop environment can successfully address the complex demands of the patient-centric supply chain. Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, Nina Vas, evaluates what is needed to develop a patient-centric supply chain in this article.